TY - INPR AV - public KW - ATRX KW - Astrocytoma KW - BRAF KW - BRAF inhibitor KW - EGFR KW - Ependymoma KW - Glioblastoma KW - Histone KW - IDH KW - MGMT KW - Mutation KW - Oligodendroglioma KW - TERT KW - Temozolomide KW - Tumour heterogeneity N2 - The emerging understanding of molecular changes in a wide range of brain tumours has led to a significant shift in how these tumours are diagnosed, managed and treated. This article will provide a hands-on overview of the relevant biomarkers and their association with newly defined biological tumour entities. A1 - Brandner, S A1 - Jaunmuktane, Z SN - 1432-1459 JF - J Neurol N1 - © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. TI - Neurological update: gliomas and other primary brain tumours in adults. Y1 - 2017/11/02/ UR - http://dx.doi.org/10.1007/s00415-017-8652-3 ID - discovery10035305 ER -